Regeneron Pharmaceuticals Up 0.8% Since Brean Capital Downgraded One Week Ago (REGN)

Published on Thu, 01/24/2013 - 10:09
By Robert Cotter in Analyst reflections, REGN, analyst reflections, nasdaq:regn, regeneron pharmaceuticals

Regeneron Pharmaceuticals was downgraded from Buy to Hold by Brean Capital one week ago. Regeneron Pharmaceuticals shares are selling at $176.16, 0.8% above the $174.84 price point of one week ago.

Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders.

Regeneron Pharmaceuticals has overhead space with shares priced $176.30, or 3.2% below the average consensus analyst price target of $182.08. The stock should find initial support at its 50-day moving average (MA) of $173.36 and further support at its 200-day MA of $144.73.

In the past 52 weeks, shares of Regeneron Pharmaceuticals have traded between a low of $42.83 and a high of $188.95 and are now at $176.30, which is 312% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.9% while the 200-day MA has risen 0.4%.

By Robert Cotter
rcotter@fnno.com

Latest News from FNNO

Earnings Flashback: Since Reporting Quar...

18 days ago, on July 8th, 2014, Bob Evans Farms (NASDAQ:BOBE) reported its earnings. A ...

Earnings Flashback: Since Reporting Quar...

11 days ago, on July 15th, 2014, CSX (NYSE:CSX) reported its earnings. Analysts, on av ...

Dover Earnings Review: 9 Days after Anno...

When Dover (NYSE:DOV) reported earnings 9 days ago on July 17th, 2014, analysts, on ave ...

Earnings Look Back: Autoliv Is Down 0.3%...

A week ago on July 18th, 2014 Autoliv (NYSE:ALV) reported earnings and analysts, on ave ...

Earnings Flashback: Since Reporting Quar...

A week ago on July 18th, 2014 Kansas City Southern (NYSE:KSU) reported earnings and ana ...

Cytec Industries Earnings Hindsight: Up ...

When Cytec Industries (NYSE:CYT) reported earnings a week ago on July 17th, 2014, analy ...

Novartis Earnings Hindsight: Down 0.1% i...

When Novartis (NYSE:NVS) reported earnings 9 days ago on July 17th, 2014, analysts, on ...

Post Earnings Update: AAR Has Climbed 4....

11 days ago, on July 15th, 2014, AAR (NYSE:AIR) reported its earnings. Analysts, on av ...

Most Popular Video News